[Theoretical Basis for Developing Cardiopulmonary Clinical Units in Patients with COPD and CVD]. [PDF]
de Miguel-Díez J +5 more
europepmc +1 more source
[Antihypertensive chronotherapy in type 2 diabetes mellitus: application degree in a community health center in central Spain]. [PDF]
Pascual-Alonso P +3 more
europepmc +1 more source
Adherence to pharmacological treatment in non-communicable chronic diseases in the Colombian population: Systematic review and meta-analysis [PDF]
Cáceres C +4 more
europepmc +1 more source
[Expanding team-based care for hypertension and cardiovascular risk management with HEARTS in the AmericasAmpliação da atenção baseada em equipe para a gestão do risco de hipertensão arterial e doenças cardiovasculares com a iniciativa HEARTS nas Américas]. [PDF]
Irazola V +16 more
europepmc +1 more source
[Deprescription in old people: It's time to take action]. [PDF]
García Pliego RA +3 more
europepmc +1 more source
[Dose adjustment according to renal function in a polymedicated patient included in the medication reconditioning service using medication compliance aids (MCA)]. [PDF]
Barris Blundell D, Mousavi H.
europepmc +1 more source
[Suspected serotonergic syndrome associated with tedizolid: a case report]. [PDF]
González-Gómez Á +5 more
europepmc +1 more source
Segurança e tolerabilidade dos fármacos antihipertensivos
A escolha de fármacos antihipertensivos baseia-se sobretudo na sua eficácia, segurança (perfil de reações adversas e interacções medicamentosas) e protecção do doente hipertenso(perfil de risco global) embora factores sócio-económicos também devam ser considerados.
openaire +1 more source

